LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.89 | 27.76 | 3805 | 7025 | 0.5416 | 0.8521 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.60 | 27.76 | 597 | 7045 | 0.0847 | 0.4684 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.60 | 27.76 | 3747 | 7045 | 0.5318 | 0.8480 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.60 | 27.76 | 552 | 7045 | 0.0783 | 0.4540 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.60 | 27.76 | 3898 | 7045 | 0.5532 | 0.8571 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.31 | 27.76 | 518 | 6976 | 0.0743 | 0.4434 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.31 | 27.76 | 3857 | 6976 | 0.5529 | 0.8567 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.31 | 27.76 | 532 | 6976 | 0.0763 | 0.4483 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.31 | 27.76 | 4028 | 6976 | 0.5774 | 0.8669 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.01 | 27.76 | 512 | 7000 | 0.0731 | 0.4410 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.01 | 27.76 | 3939 | 7000 | 0.5627 | 0.8609 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.01 | 27.76 | 534 | 7000 | 0.0763 | 0.4486 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.01 | 27.76 | 4133 | 7000 | 0.5904 | 0.8722 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.72 | 27.76 | 528 | 7055 | 0.0748 | 0.4458 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.72 | 27.76 | 4059 | 7055 | 0.5753 | 0.8663 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.72 | 27.76 | 508 | 7055 | 0.0720 | 0.4388 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.72 | 27.76 | 4212 | 7055 | 0.5970 | 0.8749 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.42 | 27.76 | 567 | 7025 | 0.0807 | 0.4592 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.42 | 27.76 | 4175 | 7025 | 0.5943 | 0.8738 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.42 | 27.76 | 562 | 7025 | 0.0800 | 0.4576 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.42 | 27.76 | 4402 | 7025 | 0.6266 | 0.8863 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.13 | 27.76 | 522 | 6987 | 0.0747 | 0.4447 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.13 | 27.76 | 4235 | 6987 | 0.6061 | 0.8783 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.13 | 27.76 | 616 | 6987 | 0.0882 | 0.4750 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.13 | 27.76 | 4488 | 6987 | 0.6423 | 0.8920 | MN20160318_Q01 | L15 |